Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2006 3
2007 2
2008 1
2009 5
2010 7
2011 3
2012 7
2013 7
2014 6
2015 4
2016 5
2017 8
2018 7
2019 2
2020 10
2021 13
2022 7
2023 6
2024 12
2025 10
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer.
Powles T, Kann AG, Castellano D, Gross-Goupil M, Nishiyama H, Bracarda S, Bjerggaard Jensen J, Makaroff L, Jiang S, Ku JH, Park SH, Reig Torras O, Ye D, Maruzzo M, Necchi A, Morales-Barrera R, Giunta EF, Lee JL, Tortora G, Ürün Y, Dolowy L, Erdem D, Pinto A, Grando F, Zou W, Assaf ZJ, Vuky J, Degaonkar V, Steinberg EE, Bellmunt J, Gschwend JE; IMvigor011 Investigators. Powles T, et al. N Engl J Med. 2025 Dec 18;393(24):2395-2408. doi: 10.1056/NEJMoa2511885. Epub 2025 Oct 20. N Engl J Med. 2025. PMID: 41124204 Clinical Trial.
Mitostemness.
Cuyàs E, Verdura S, Folguera-Blasco N, Bastidas-Velez C, Martin ÁG, Alarcón T, Menendez JA. Cuyàs E, et al. Among authors: martin ag. Cell Cycle. 2018;17(8):918-926. doi: 10.1080/15384101.2018.1467679. Epub 2018 Jul 2. Cell Cycle. 2018. PMID: 29886796 Free PMC article. Review.
Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial.
Pal SK, Albiges L, Tomczak P, Suárez C, Voss MH, de Velasco G, Chahoud J, Mochalova A, Procopio G, Mahammedi H, Zengerling F, Kim C, Osawa T, Angel M, Gupta S, Khan O, Bergthold G, Liu B, Kalaitzidou M, Huseni M, Scheffold C, Powles T, Choueiri TK. Pal SK, et al. Among authors: angel m. Lancet. 2023 Jul 15;402(10397):185-195. doi: 10.1016/S0140-6736(23)00922-4. Epub 2023 Jun 5. Lancet. 2023. PMID: 37290461 Free PMC article. Clinical Trial.
Information Management.
Labarga A, Beloqui I, Martin AG. Labarga A, et al. Among authors: martin ag. Methods Mol Biol. 2017;1590:29-39. doi: 10.1007/978-1-4939-6921-0_4. Methods Mol Biol. 2017. PMID: 28353261 Review.
Cancer Treatment Adaptations in the COVID-19 Era.
Waisberg F, Enrico D, Angel M, Chacón M. Waisberg F, et al. Among authors: angel m. JCO Oncol Pract. 2020 Jun;16(6):305-307. doi: 10.1200/OP.20.00218. Epub 2020 Apr 23. JCO Oncol Pract. 2020. PMID: 32324487 Free PMC article. No abstract available.
[Vitamin D deficiency].
Aguirre M, Manzano N, Salas Y, Angel M, Díaz-Couselo FA, Zylberman M. Aguirre M, et al. Among authors: angel m. Medicina (B Aires). 2015;75(6):426-7. Medicina (B Aires). 2015. PMID: 26707675 Free article. Spanish. No abstract available.
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study.
Pichler R, Klinglmair G, Binz K, Grande E, Pirshtuk A, Takeshita H, Ürün Y, Molina-Cerrillo J, Myint ZW, de Liaño AG, Mota A, Salfi A, Fukuokaya W, Sammarco E, Angel M, Kucharz J, Tural D, Fiala O, Rodriguez-Vida A, Morelli F, Poprach A, Safi M, Pinto A, Massari F, Buti S, Gupta S, Monteiro FSM, Soares A, Battelli N, Kanesvaran R, Santoni M. Pichler R, et al. Among authors: angel m. Clin Exp Metastasis. 2025 Nov 21;43(1):1. doi: 10.1007/s10585-025-10382-x. Clin Exp Metastasis. 2025. PMID: 41269368 Free PMC article.
Enfortumab Vedotin Following Platinum Chemotherapy and Avelumab Maintenance in Patients with Metastatic Urothelial Carcinoma: A Retrospective Data from the ARON-2EV Study.
Fiala O, Massari F, Basso U, Giannatempo P, Grande E, Buti S, Myint ZW, De Giorgi U, Pichler R, Grillone F, Ürün Y, Calabrò F, Bourlon MT, Galli L, Kanesvaran R, Roviello G, Kucharz J, Rizzo M, Park SH, Cerbone L, Seront E, Messina C, Molina-Cerrillo J, Santini D, Yano A, Incorvaia L, Catalano M, Pinto A, Formisano L, Soares A, Facchini G, Fornarini G, Poprach A, Rebuzzi SE, Nasso C, Spinelli GP, Angel M, Stellato M, Tural D, Aurilio G, Epstein I, Carrozza F, Monteiro FSM, Benedetti G, Büchler T, Ortega C, Zakopoulou R, Battelli N, Porta C, Bellmunt J, Gupta S, Santoni M. Fiala O, et al. Among authors: angel m. Target Oncol. 2024 Nov;19(6):905-915. doi: 10.1007/s11523-024-01099-0. Epub 2024 Oct 1. Target Oncol. 2024. PMID: 39354179 Free PMC article.
Cryobanking Mesenchymal Stem Cells.
Pavón A, Beloqui I, Salcedo JM, Martin AG. Pavón A, et al. Among authors: martin ag. Methods Mol Biol. 2017;1590:191-196. doi: 10.1007/978-1-4939-6921-0_14. Methods Mol Biol. 2017. PMID: 28353271
123 results